Hexarelin, a synthetic GH-releasing peptide, is a powerful stimulus of GH secretion in pubertal children and in adults but not in prepubertal children and in elderly subjects

Journal of Endocrinological Investigation

Volumn 21, Issue 8, 1998, Pages 494-500

  Bellone, J ^a   Bartolotta, E ^b   Sgattoni, C ^b   Aimaretti, G ^a   Arvat, E ^a   Bellone, S ^a   Deghenghi, R ^c   Ghigo, E ^a,d  

^a UNIVERSITY OF TURIN   (Italy)

^b Divisione di Pediatria di Recanati   (Italy)

^c Ardana   (France)

^d MOLINETTE HOSPITAL   (Italy)

Author keywords

Arginine; GH; GHRH; GHRPs; Hexarelin

Indexed keywords

ARGININE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR DERIVATIVE; HEXARELIN; SERMORELIN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PREPUBERTY; PROVOCATION TEST; PUBERTY; SHORT STATURE; SOMATOSTATIN RELEASE;

EID: 0031662260     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347334     Document Type: Article

References (48)

1. Bowers C.Y. GH releasing peptides; structure and kinetics. J. Pediatr. Endocrinol. 6: 21, 1993.
2. Ghigo E., Arvat E., Gianotti L., Grottoli S., Rizzi G., Ceda G.P., Deghenghi R., Camanni F. Aging and GH-releasing peptides. In: Bercu B., Walker R., (Eds.), Growth Secretagogues. Springer-Verlag, New York, 1996, p. 415.
3. Korbonits M., Grossman A.B. Growth hormone releasing peptides and its analogs. Novel stimuli to growth hormone release. Trends in Endocrinology and Metabolism 6: 43, 1995.
4. De Vita R.J., Wyvratt M.J. Benzolactam growth hormone secretagogues. Drugs of the Future 21: 273, 1996.
5. Pong S.S., Chaung L.Y.P., Dean D.C., Nargunt R.P., Pat Chett A.A., Smith R.G. Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol. Endocrinol. 10: 57, 1996.
6. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I., Uamelin M., Ureniuk D.I., Palyhe O.C., Anderson J., Paress P.S., Diaz C., Chou N., Liu K.K., McKee K.K., Pong S.S., Cheung L.Y., Elbrecht A., Dashkevicz M., Keavesh R., Rishy M., Siringjhsinghji D.J.S., Dean D.C., Melillo D.G., Patchett A.A., Nergund R., Srillin P.R. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273: 974, 1996.
7. Goth M.I., Lyons C.E., Canny B.Y., Thorner M.O. Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through pituitary receptors. Endocrinology 130: 939, 1992.
8. Fairhall K.M., Mynett A., Robinson I.C. Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action. J. Endocrinol. 144: 555, 1995.
9. Dickson S.L., Leng G., Dyball R.E.J., Smith R.G. Central actions of peptide and non-peptide growth hormone secretagogues in the rat. Neuroendocrinology 61: 36, 1995.
10. Dickson S.L., Luckman S.M. Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurones in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology 138: 771, 1997.
11. Arvat E., Gianotti L., Di Vito L., Imbimbo B.P., Lenaerts V., Deghenghi R., Camanni F., Ghigo E. Modulation of growth hormone-releasing activity of hexarelin in man. Neuroendocrinology 61: 51, 1995.
12. Mallo F., Alvarez C.V., Benitez L., Burguera B., Coya R., Casanueva F.F., Dieguez C. Regulation of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 (GHRP6)-induced GH secretion in the rat. Neuroendocrinology 57: 247, 1993.
13. Popovic V., Damjanovic S., Micic D., Djurovic M., Dieguez C., Casanueva F.F. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamo-pituitary disconnection: evidence that GHRP-6 main action is exterted at the hypothalamic level. J. Clin. Endocrinol. Metab. 80: 942, 1995.
14. Pombo M., Barreiro J., Penalva A., Peino R., Dieguez C., Casanueva F.F. Absence of growth hormone (GH) secretion after the administration of either GH releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection. J. Clin. Endocrinol. Metab. 80: 3180, 1995.
15. Loche S., Cambiaso P., Carta D., Setzu S., Imbimbo B.P., Borrelli P., Pintor C., Cappa M. The growth hormone-releasing activity of Hexarelin, a new synthethic hexapeptide, in short normal and obese children and in hypopituitary subjects. J. Clin. Endocrinol. Metab. 80: 476, 1995.
16. Bellone J., Aimaretti G., Bartolotta E., Benso L., lmbimbo B.P., Lenhaerts V., Deghenghi R., Camanni F., Ghigo E. Growth hormone-releasing activity of Hexarelin, a new synthetic hexarepeptide, before and during puberty. J. Clin. Endocrinol. Metab. 80: 1090, 1995.
17. Loche S., Colao A., Cappa M., Bellone J., Aimaretti G., Farello G., Faedda A., Lombardi G., Deghenghi R., Ghigo E. The growth hormone response to Hexarelin in children: reproducibility and effect of sex steroid. J. Clin. Endocrinol. Metab. 82: 861, 1997.
18. Arvat E., Gianotti L., Grottoli S., Imbimbo B.P., Lenaerts V., Deghenghi R., Camanni F., Ghigo E. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects. J. Clin. Endocrinol. Metab. 79: 1440, 1994.
19. Arvat E. Gianotti L., Broglio F., Maccagno B., Bertagna A., Deghenghi R., Camanni F., Ghigo E. Oestrogen replacement does not restore the reduced GH-releasing activity of Hexarelin, a synthetic hexapeptide, in post-menopausal women. Eur. J. Endocrinol. 136: 483, 1997.
20. Ghigo E., Arvat E., Rizzi G., Bellone J., Nicolosi M., Boffano G.M., Mucci M., Boghen M.F., Camanni F. Arginine enhances the growth hormone (GH)-releasing activity of a synthetic hexapeptide (GHRP-6) in elderly but not in young subjects after oral administration. J. Endocrinol. Invest., 17: 157, 1994.
21. Aloi J.A., Gertz B.J., Hartman M.L., Huhn W.C., Pezzoli S.S., Wittreich M., Krupa D.A., Thorner M.O. Neuroendocrine responses to a novel growth hormone secretagogue, L-692, 429 in healthy older subjects. J. Clin. Endocrinol. Metab. 79: 943, 1994.
22. Laron Z. Growth hormone secretagogues. Drugs 50: 95, 1995.
23. Pombo M., Barreiro J., Penalva A., Mallo F., Casanueva F.F., Dieguez C. Plasma growth hormone response to growth hormone releasing hexapeptide (GHRP-6) in children with short stature. Acta Paed. 84: 908, 1995.
24. Leal-Cerro A., Garcia E., Astorga R., Casanueav F.F., Dieguez C. Growth Hormone (GH) responses to the combined administration of GH-releasing peptide 6 in adults with GH deficiency. Eur. J. Endocrinol. 132: 712, 1995.
25. De Boer H., Blok G., Van der Veen E. Clinical aspects of growth hormone dificiency in adults. Endocr. Rev. 16: 1: 63, 1995.
26. Rosenfeld R.G., Albertsson-Wiekland K., Cassorla F., Frasier S.D., Hasegawa Y., Hintz R.L., Lafranchi S., Lippe B., Loriaux L., Melmed S., Preece M.A., Ranke M.B., Reiter E.O., Rogol A.D., Underwood L.E., Werther G.A. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisied. J. Clin. Endocrinol. Metab. 80: 1532, 1995.
27. Cacciari E., Tassoni P., Cicognani A., Pirazzoli P., Salardi S., Balsamo A., Cassio A., Zucchini S., Colli C., Tassinari D., Tani G., Gualandi S. Value and limits of pharmacological and physiological tests to diagnose growth hormone (GH) deficiency and predict therapy response: first and second retesting during replacement therapy of patients defied as GH deficiency. J. Clin. Endocrinol. Metab. 79: 663, 1994.
28. Ghigo E., Imperiale E., Boffano G.M., Mazza E., Bellone J., Arvat E., Procopio M., Goffi S., Barrera A., Chiabotto P., Lala R., De Sanctis C., Muller E.E., Camanni F. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone releasing hormone. J. Endocrinol. Invest., 13: 307, 1990.
29. Ghigo E., Bellone J., Aimaretti G., Bellone S., Loche S., Cappa M., Bartolotta E., Dammacco F., Camanni F. Reliability of provocative test to assess growth hormone secretory status. Study in 472 normally growing children. J. Clin. Endocrinol. Metab. 81: 323, 1996.
30. Ghigo E., Bartolotta E., Imperiale E., Cardinale G., Valetta M.R., Cherubini V., Bellone J., Maccario M., Cocchi D., Camanni F. Glucagon per se is not a real GH secretagogue. J. Endocrinol. Invest. 17: 849, 1994.
31. Toogood A.A., Shalet S.M. The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clin. Endocrinol. (Oxf.) 134: 352, 1994.
32. Hoffman D.M., O'Sullivan A.J., Baxter R.C., Ho K.Y.Y. Diagnosis of growth hormone deficiency in adults. Lancet I: 1064, 1994.
33. Ghigo E., Aimaretti G., Gianotti L., Bellone J., Arvat E., Camanni F. New approach to the diagnosis of growth hormone deficiency in adults. Eur. J. Endocrinol. 134: 352, 1996.
34. Andersen M., Hansen T.B., Stoving R.K., Bertelsen J., Hangard J., Hyltoft Petersen P., Hagen C. The pyridostigmine-growth hormone releasing hormone test in adults. The reference interval and a comparison with the insulin tolerance test. Endocrinol. Metab. Clin. North Am. 3: 197, 1996.
35. Hoeck H.C., Vestergaard P., Jacobsen P.E., Lauberg P. Test of growth hormone secretion in adults: poor reproducibility of the insulin tolerance test. Eur. J. Endocrinol. 133: 305, 1995.
36. Vestergaard P., Hoeck H.C., Jacobsen P.E., Laurberg P. Reproducibility of growth hormone and cortisol responses to the insulin tolerance test and the short ACTH test in normal adults. Horm. Metab. Res. 29: 106, 1997.
37. Alba-Roth J., Muller O.A., Schopohl J., Von Werder K. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J. Clin. Endocrinol. Metab. 67: 1186, 1988.
38. Valetto M.R., Bellone J., Baffoni C., Savio P., Aimaretti G., Gianotti L., Arvat E., Camanni F., Ghigo E. Reproducibility of the growth hormone response to stimulation with growth hormone-releasing hormone plus arginine during lifespan. Eur. J. Endocrinol. 135: 568, 1996.
39. Ghigo E., Goffi S., Nicolosi M., Arvat E., Valente F., Mazza E., Ghigo M.C., Camanni F. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. J. Clin. Endocrinol. Metab. 71: 1481, 1990.
40. Deghenghi R., Boutignon F., Luoni M., Grilli R., Guidi M., Locatelli V. Small peptides as potent releasers of growth hormone. J. Ped. Endocrinol. Metab. 8: 311, 1995.
41. Imbimbo B.P., Mant T., Edwards M., Amin D., Froud A., Lenaerts U., Boutignon F., Deghenghi R. Growth hormone releasing activity of hexarelin in humans: a dose-response study. J. Clin. Pharmacol. 46: 421, 1994.
42. Ghigo E., Arvat E., Gianotti L., Imbimbo B.P., Lenaerts V., Deghenghi R., Camanni F. Growth hormone releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranansal and oral administration in man. J. Clin. Endocrinol. Metab. 78: 693, 1994.
43. Kerrigan J.R., Rogol A.D. The impact of gonadal steroid hormone action on growth hormone secretion during childood, and adolescence. Endocrinol. Rev. 13: 281, 1992.
44. Ho K.Y., Evans W., Blizzard R.M., Veldhuis J.D., Merrian G.R., Samojlik E., Furlanetto R., Rogol A.D., Kaiser D.L., Thorner M.O. Effects of sex and age on the 24 hour profile of GH secretion in man: importance of endogenous estradiol concentration. J. Clin. Endocrinol. Metab. 64: 51, 1987.
45. Muller E.E., Nisticò G. Neurotransmitter regulation of the anterior pituitary. Brain messenger and the pituitary. San Diego: Academic Press, 1989, p. 404.
46. Ghigo E., Arvat E., Bellone J., Ramunni J., Camanni F. Neurotransmitter control of growth hormone secretion in humans. J. Ped. Endocrinol. Metab. 6: 263, 1993.
47. Bowers C.Y., Reynolds G.A., Field A., Arkiek A., Kaf-Alghazal A., Krishnamurthi L., Granda Ayala R. Independency, dependency and synergism of GHRP-2 and GHRH on GH release in humans. Endocrine Society, abstract book P3-61 770, 1990.
48. Aimaretti G., Corneli G., Razzone P., Bellone S., Arvat E., Camanni F., Ghigo E. Comparison between insulin-induced hypoglycemia (ITT) and GHRH+Arginine as provocative test for the diagnosis of GH deficiency (GHD) in adults. J. Clin. Endocrinol. Metab. 83: 1615, 1998.